TMD IMPACT 2024/ NIDCR
The National Institute of Dental and Craniofacial Research (NIDCR)
Funding Opportunity Alert: Temporomandibular Disorder Research Collaboration (TMD IMPACT)
The National Institute of Dental and Craniofacial Research (NIDCR) is planning a new initiative to improve research on Temporomandibular Disorders (TMD). Here’s a summary:
What is the opportunity?
- The NIDCR, along with partners, will release a grant for a research collaborative called TMD IMPACT.
- TMD IMPACT aims to be a national, interdisciplinary effort focused on patient-centered TMD research.
- The goal is to improve basic and clinical TMD research, train future researchers, and translate findings into better treatments and care.
What are the key objectives?
- Support fundamental TMD research leading to practical applications and deeper understanding of the condition.
- Develop programs to translate research into improved diagnosis, prevention, and treatment of TMDs.
- Strengthen research on the public health impact of TMDs and translate findings into better prevention, management, and healthcare practices.
- Train the next generation of TMD researchers from diverse backgrounds and disciplines.
Key Details
- Grant Program: TMD Collaborative for Improving Patient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional) – The “U54” designation indicates a cooperative agreement to support a center with collaborative research activities. The “Clinical Trial Optional” part means the center may or may not include clinical trials as part of its research.
- Funding Agency: National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR)
- Estimated Posting Date: August 30, 2024
- Estimated Application Due Date: December 13, 2024
- Expected Award Ceiling: $3,500,000 (This is the maximum amount a single award can be. The total program funding may be higher depending on the number of awards given.)
Who can Apply?
A wide range of organizations are eligible to apply, including:
- Universities (public and private)
- Non-profit organizations with 501(c)(3) status (excluding universities)
- Tribal governments (federally recognized and other)
- State and local governments
- Small businesses
- For-profit organizations
What’s Next?
The official announcement (expected in August 2024) will provide full details about the program, including:
- Specific research priorities for TMD IMPACT
- Requirements for participating in the TMD IMPACT collaborative
- Evaluation criteria for applications
- Instructions for submitting an application
Stay Tuned!
Keep an eye out for the official announcement titled “Notice of Funding Opportunity (NOFO) for TMD Collaborative for Improving Patient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional)”. This will provide all the information you need to apply. Note: While the grant is offered by a U.S. government agency, the research itself can be conducted in various locations.
What is TMD IMPACT?
- TMD IMPACT stands for Temporomandibular Disorder Collaborative for Improving Patient-Centered Translational Research.
- It aims to establish a powerful, nationwide research effort focused on TMD, with a strong emphasis on incorporating patient needs and experiences.
- This collaborative approach will bring together researchers from various disciplines to tackle TMD challenges.
What are the Goals?
- To advance both basic and clinical research on TMD, leading to a deeper understanding of the condition and more effective treatments.
- To develop programs that translate research findings into practical applications, ultimately improving diagnosis, prevention, and treatment options for TMD patients.
- To strengthen research on the public health impact of TMDs. This includes understanding the overall burden on healthcare systems and developing strategies for better prevention and management.
- To train the next generation of TMD researchers, fostering a diverse and well-equipped workforce.
Funding Details
- Grant Program: TMD Collaborative for Improving Patient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional)
- “U54” indicates a cooperative agreement to support a collaborative research center.
- “Clinical Trial Optional” means the center may or may not include clinical trials as part of its research.
- Funding Agency: National Institutes of Health (NIH), National Institute of Dental and Craniofacial Research (NIDCR)
- Estimated Posting Date: August 30, 2024
- Estimated Application Due Date: December 13, 2024
- Expected Award Ceiling per Center: $3,500,000 (The total program funding is $7,000,000 and may be divided among multiple awarded centers.)
Who Can Apply?
A wide range of organizations can apply, including:
- Public and private universities
- Non-profit organizations (excluding universities) with 501(c)(3) status
- Tribal governments (both federally recognized and others)
- State and local government agencies
- Small businesses
- For-profit organizations (excluding small businesses)
What’s Next?
The official announcement (expected in August 2024) will provide complete details, including:
- Specific research priorities for TMD IMPACT centers
- Requirements and expectations for participating institutions
- Evaluation criteria for proposals
- Instructions for submitting an application
Stay Informed!
Keep an eye out for the official announcement titled “Notice of Funding Opportunity (NOFO) for TMD Collaborative for Improving Patient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional)”. This will provide all the information you need to apply.
Additional Notes:
- While the grant is offered by a U.S. government agency, the research itself can be conducted in various locations around the world.
- TMD is a disorder of the jaw muscles and joints that can cause pain, headaches, and difficulty chewing. It’s a common condition, affecting millions of people globally.
